IP Library Granted Patent US 8,372,452
Granted Patent B2
US 8,372,452 · App. 13/001,268 · Granted Feb 12, 2013

Oral herbal composition for the treatment of oral candidiasis

Inventors: Vijay Singh Chauhan (Mumbai, IN); Kavita Sujeet Salkar (Mumbai, IN)
Assignee: Piramal Life Sciences Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,452
App. No.
13/001,268
Granted
Feb 12, 2013
Kind
B2
Abstract

An oral herbal composition comprising a therapeutically effective amount of an extract derived from the berries of a plant, Piper cubeba , wherein the composition is provided for use in the treatment of oral candidiasis (oral thrush). The oral herbal composition can be formulated in the form of a candy, a chewable tablet and an oral gel. The herbal composition exhibits antifungal activity against azole resistant strains of Candida albicans . The herbal composition is safe to administer and has improved patient compliance.

Claims (23)

1. An oral herbal composition for use in the treatment of oral candidiasis, said composition comprising 0.05 to 20% by weight of a petroleum ether extract of Piper cubeba ( P. cubeba ) berries in viscous oil form and at least one pharmaceutically acceptable excipient.

2. The oral herbal composition according to claim 1 , wherein the oral candidiasis is the azole resistant candidiasis.

3. The oral herbal composition according to claim 1 , wherein the composition is formulated in a form selected from the group consisting of a candy, a chewable tablet and an oral gel.

4. The oral herbal composition according to claim 1 , wherein the oral candidiasis is caused by candida species selected from the group consisting of Candida albicans, Candida krusei and Candida glabrata.

5. The oral herbal composition according to claim 1 , wherein said pharmaceutically acceptable excipient is selected from the group consisting of a binder, lubricant, flavouring agent, sweetening agent, colouring agent, and preservative.

6. The oral herbal composition according to claim 5 , wherein the binder is selected from the group consisting of starch paste, sorbitol, guar gum, polyvinyl pyrrolidone, hydroxy propylmethyl cellulose, sodium carboxymethyl cellulose and carbomer.

7. The oral herbal composition according to claim 5 , wherein the lubricant is selected from the group consisting of magnesium, calcium and sodium stearates, stearic acid, talc, polyethylene glycols, sodium chloride and sodium benzoate.

8. The oral herbal composition according to claim 5 , wherein the flavouring agent is selected from the group consisting of peppermint oil, menthol, lemon oil, orange oil and cinnamon oil.

9. The oral herbal composition according to claim 5 , wherein the sweetening agent is selected from the group consisting of sucrose, liquid glucose, sucralose, mannitol, aspartame and saccharin sodium.

10. The oral herbal composition according to claim 3 , wherein said composition is formulated in the form of a candy.

11. A process for manufacture of an oral herbal composition comprising a therapeutically effective amount of Piper cubeba ( P. cubeba ) extract and at least one pharmaceutically acceptable excipient; wherein said process comprises the steps of:

a) obtaining the berries of P. cubeba;

b) drying the P. cubeba berries in shade;

c) pulverising the dried berries of P. cubeba to obtain a fine powder;

d) extracting repeatedly the fine powder obtained in step (c) with petroleum ether;

e) concentrating the extract under vacuum to obtain a concentrated liquid extract in viscous oil form; and

f) formulating the extract which is in viscous oil form with at least one pharmaceutically acceptable excipient to obtain the oral herbal composition, said composition comprising 0.05 to 20% by weight of the extract.

12. The process according to claim 11 , wherein petroleum ether is used in an amount two fold (weight/volume) the amount of the fine powder of P. cubeba berries.

13. The process according to claim 11 , wherein the extraction is carried out at a temperature of about 35° C. to 40° C. and a pressure of about 1 atmosphere.

14. A method for the treatment of oral candidiasis in a subject, wherein said method comprises administering to the subject in need thereof a therapeutically effective amount of the oral herbal composition of claim 1 .

15. The method according to claim 14 , wherein the oral candidiasis is the azole resistant oral candidiasis.

16. The method according to claim 14 , wherein said oral herbal composition is formulated in the form of a candy, chewable tablet and an oral gel.

17. The method according to claim 16 , wherein said oral herbal composition is formulated in the form of a candy.

Assignments (3)
CHANGE OF NAME Recorded May 8, 2013
From: PIRAMAL HEALTHCARE LIMITED
To: PIRAMAL ENTERPRISES LIMITED
Reel/Frame 030376/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2013
From: PIRAMAL LIFE SCIENCES LIMITED
To: PIRAMAL HEALTHCARE LIMITED
Reel/Frame 030351/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2010
From: CHAUHAN, VIJAY SINGH; SALKAR, KAVITA SUJEET
To: PIRAMAL LIFE SCIENCES LIMITED
Reel/Frame 025571/0570 →
Priority Claims (1)
IN 1340/MUM/2008 · Jun 26, 2008 · national
Continuity (1)
Related Publication 20110111067A1 · May 12, 2011